腹腔镜减肥手术中腹腔内注射布比卡因的疗效
Efficacy of intraperitoneal bupivacaine in laparoscopic bariatric surgery.
作者信息
Saafan Tamer, Abounozha Sabry, Obaid Munzir, Ghali Mohamed Said
机构信息
General Surgery Department, Northumbria Healthcare NHS Foundation Trust, Northumbria, UK.
Acute Care Surgery Department, Hamad Medical Corporation, Doha, Qatar.
出版信息
Ann Med Surg (Lond). 2022 Jan 7;73:103229. doi: 10.1016/j.amsu.2021.103229. eCollection 2022 Jan.
A best evidence topic has been constructed using a described protocol. The three-part question addressed was: In [patients undergoing bariatric surgery], is [intraperitoneal local bupivacaine during the operation ] associated with [ lower pain score and decrease in post operative pain medications]? The search has been done and six randomized trial studies are considered to be appropriate to answer this question. The outcome assessed is the value of intraperitoneal bupivacaine in bariatric surgery in terms of effect on the pain score and post operative analgesia. We concluded that intraperitoneal bupivacaine causes improvement in both the pain score and post operative analgesia.
一个最佳证据主题已按照既定方案构建。所提出的三部分问题是：在[接受减肥手术的患者]中，[术中腹腔内局部使用布比卡因]是否与[更低的疼痛评分及术后止痛药物使用减少]相关？检索工作已经完成，六项随机试验研究被认为适合回答这个问题。评估的结果是腹腔内布比卡因在减肥手术中对疼痛评分和术后镇痛的影响。我们得出结论，腹腔内布比卡因可改善疼痛评分和术后镇痛效果。
Zotero 插件